The study was conducted by Pamyaphy NG, Pushpita Behera and Priti S. Dhawan, researchers based at Lady Shri Ram College for Women in New Delhi, India. Their sample consisted of 96 participants above the age of sixty, selected through purposive sampling, a non-random technique in which participants are deliberately chosen because they belong to the population of interest. The participants were divided into three age brackets: sixty to sixty-nine years, seventy to seventy-nine years, and eighty years and above. They were also split by educational attainment into two groups: those educated up to the twelfth standard, roughly equivalent to secondary school completion, and those who had completed graduation or higher.

The Mini Mental Status Examination, first developed by Folstein, Folstein and McHugh in 1975, is a brief screening tool that samples several cognitive domains, including orientation to time and place, registration and recall of words, attention and calculation, language ability, and visuoconstructional skills such as copying intersecting figures. It yields a total score commonly used to flag global cognitive impairment. The Trail Making Test, by contrast, is a measure of executive functioning, the umbrella term for the mental processes that allow people to plan, sequence, shift attention and manage competing demands. In Part A of the test, the participant draws lines connecting numbered circles in ascending order as quickly as possible; in Part B, they must alternate between numbers and letters, connecting one to A, two to B, and so on. Part B is considerably more demanding because it requires the participant to hold and switch between two sequences simultaneously, making it a sensitive indicator of frontal lobe function and cognitive flexibility. In both parts, the key measure is the time taken to complete the task, with longer completion times indicating poorer performance.

The researchers used an independent samples t-test to compare the two educational groups on executive functioning and global cognitive ability, and a one-way analysis of variance, or ANOVA, to compare the three age groups on TMT performance, with Tukey post-hoc tests to pinpoint exactly which age groups differed from one another. This combination of statistical tools allowed the team to separate the effects of chronological age from the effects of education, a distinction that matters enormously in both clinical screening and cognitive theory.

The results were striking on both fronts. Higher education was associated with significantly lower impairment on executive functioning as measured by the Trail Making Test, meaning that participants with graduate-level education completed the tasks faster and more accurately than their less-educated peers. The researchers interpret this through the well-established concept of cognitive reserve, the idea, developed most prominently by Yaakov Stern, that education and mentally stimulating experience build a network of neural resources that allows the brain to withstand age-related damage longer before symptoms of decline become visible. In other words, individuals with more schooling may be able to compensate for underlying neural change, performing as if their brains were younger than their chronological age would suggest.

On the MMSE, however, the relationship with education was far more nuanced. Of all the subcomponents of the examination, only one, attention and calculation, showed a negative correlation with years of education, while the other domains did not follow the same clear pattern. This partial dissociation is telling. It suggests that education does not uniformly buffer every cognitive domain. Some abilities, particularly those requiring sustained attention, working with numbers and mental manipulation, appear more closely tied to educational experience, whereas domains such as orientation or language recall may be more resistant to schooling effects or more tightly governed by age-related neural change.

Age, unsurprisingly, left its mark. Older participants performed more poorly across various MMSE scores as well as on both parts of the Trail Making Test. But the study’s most clinically valuable contribution is its fine-grained mapping of when decline accelerates. The researchers observed a marked and statistically significant drop in performance on TMT Part B at age seventy and above. This is significant because Part B is the more cognitively complex portion of the test, drawing on set-shifting, divided attention and sequencing, capacities known to be vulnerable to frontal lobe aging. In contrast, performance on Part A, the simpler visuomotor scanning task, did not deteriorate significantly until participants reached eighty years and above. The practical implication is that a marked slowdown on the alternating-number-letter task may signal the onset of meaningful executive decline a decade before the simpler task shows comparable deterioration.

The study also found that MMSE total scores were inversely related to the time taken to complete the Trail Making Test, meaning that individuals with higher global cognitive scores tended to finish the trails faster. This correlation between a screening instrument and an executive measure reinforces the coherence of the two tools as complementary windows onto brain health, and it aligns with earlier findings that trail-making speed predicts not only cognitive status but also physical impairment and even mortality in older populations.

The study arrives at a moment when population aging has become one of the defining demographic realities of the century. According to data cited in the article from the United Nations Department of Economic and Social Affairs and the Indian Ministry of Statistics and Programme Implementation, the proportion of older adults is rising rapidly worldwide, and India’s elderly population is growing particularly fast. As more people live into their eighties and beyond, the ability to distinguish normal age-related cognitive change from pathological decline becomes a pressing public health priority. Screening tools like the MMSE and TMT are inexpensive, fast and easy to administer, but their interpretation depends heavily on knowing what constitutes normal performance for a given age and educational background, and normative data from developing countries has historically been sparse.

That context gives the study particular weight. Much of the existing normative literature for the MMSE and TMT comes from Western, highly educated populations, and applying those benchmarks to individuals with little or no formal schooling can lead to misleading conclusions, either flagging normal performance as impaired or missing genuine decline. Studies from Turkey, Brazil, Japan and South India have each contributed region-specific norms, and this new research adds to that effort by quantifying how both age and education shift performance in an Indian sample.

The findings also connect to a long-running theoretical debate in cognitive aging research. Early anatomical studies reported substantial neuronal loss with age, while later quantitative work, including the classic investigations of dendritic growth in the aging human brain, revealed that normal aging brains retain a capacity for structural plasticity even into old age, growth that fails to occur in dementia. This biological substrate of plasticity is precisely what theories of cognitive reserve invoke: lifelong mental activity, of which education is the most measurable proxy, may support the dendritic arborization and network redundancy that keep older brains functioning well. The dual-process models of adult intelligence developed by Paul Baltes and colleagues in the 1980s similarly distinguished between fluid mechanics of intelligence, which decline steadily with age, and crystallized pragmatics, which can be maintained or even expanded through experience, and the present results echo that distinction, with speed-dependent executive tasks declining earlier than education-buffered abilities.

For clinicians, the practical takeaways are concrete. When screening an older adult for cognitive impairment, the TMT Part B should be watched closely from age seventy onward, because a significant slowdown there may mark the transition from normal aging to clinically meaningful executive dysfunction. TMT Part A remains a useful indicator of broader decline, but its deterioration appears later, around eighty. Education level must be factored into the interpretation of any score, since the same completion time may reflect impairment in one person and simply less practice with paper-and-pencil tasks in another. And the MMSE, while a valuable global screen, should be interpreted with attention to its individual subcomponents, since education affects them unevenly.

The authors acknowledge that the sample was modest in size and selected purposively rather than randomly, which limits how broadly the findings can be generalized. Longitudinal follow-up, in which the same individuals are tracked over years, would strengthen conclusions about whether the observed age thresholds represent true inflection points in decline. Even so, the study contributes a clear empirical message: the aging brain does not decline on a single schedule, and the autumn of life unfolds differently depending on what cognitive resources a person has accumulated along the way.

The study deftly explores the intricate relationship between our internal biological clocks and memory processing, arguing that both age and sex have profound influences on these mechanisms. Circadian rhythms, which govern various physiological processes in roughly 24-hour cycles, are crucial not only for sleep-wake patterns but also for cognitive functions such as memory consolidation. Understanding these relationships can potentially inform strategies for improving cognitive health across different demographics, emphasizing the importance of personalized approaches to memory-related therapies.

At the center of this research is the gene Per1, a pivotal component of the circadian rhythm pathway. Its expression entails a series of biochemical interactions that synchronize the body’s internal clock with environmental cues such as light and temperature. The study highlights that variations in the expression levels of Per1 significantly correlate with changes in diurnal memory oscillations, suggesting that our cognitive abilities may be more closely tied to circadian regulation than previously understood.

The findings reveal that younger individuals tend to display more pronounced diurnal fluctuations in memory performance compared to older adults. As individuals age, these oscillations seem to diminish, pointing to potential declines in cognitive flexibility and adaptability. This shift could have meaningful implications for developing cognitive enhancement programs that cater to specific age groups, particularly aimed at maintaining optimal cognitive function throughout aging.

Moreover, the research underscores noted distinctions in how males and females experience these memory oscillations and circadian patterns. Hormonal fluctuations in females, particularly those related to the menstrual cycle, are hypothesized to impact memory performance and rhythms. This added layer of gender dynamics adds complexity to our understanding of cognition and biological rhythms, presenting opportunities for exploring sex-specific cognitive interventions.

The authors employed a comprehensive methodology involving molecular assays alongside cognitive tests to elucidate the underlying connections between Per1 expression and memory performance. By combining physiological measurements with behavioral assessments, this study paves the way for future multi-faceted explorations into how circadian biology interplays with cognitive health across life stages.

In addition to individual differences across age and sex, the study also addresses external factors such as lifestyle and environmental influences on circadian rhythms. Modern life, characterized by irregular sleep patterns and exposure to artificial light, can disrupt our natural rhythms and potentially compromise memory performance. Thus, the research calls for a nuanced approach to lifestyle interventions that consider both biological proclivities and external environmental factors.

Further enriching the discussion, the paper emphasizes the potential for circadian-based therapies that could ameliorate memory-related issues, particularly in aging populations. By implementing strategies that align with natural circadian rhythms—such as optimal light exposure and timing of cognitive tasks—there may be opportunities to enhance memory function and overall cognitive health.

Additionally, the research opens up possibilities for technological applications and interventions designed to remind individuals of optimal times for memory-engaging activities based on their unique circadian profiles. As interdisciplinary approaches merge psychology with chronobiology, the resulting insights could revolutionize how we understand and facilitate cognitive health.

As society grapples with increasing cognitive challenges related to aging demographics, this study serves as a clarion call for further exploration into the subtle yet powerful connections between our biological clocks and cognitive functioning. With rising interest in personalized medicine, findings such as these illustrate the importance of integrating genomic factors with behavioral science to foster better health outcomes.

By investigating the genetic underpinnings of circadian rhythms and cognitive performance as outlined here, we take a step closer to comprehensively understanding human cognition and memory. As research continues to evolve, future studies are likely to delve deeper into the genetic, hormonal, and environmental influences shaping these pivotal aspects of our lives.

In conclusion, the intersection of age, sex, and circadian biology presents a rich landscape for scientific inquiry. The remarkable insights provided by this study signal a promising direction for future research that directly influences how we approach cognitive health interventions, potentially altering lives through tailored approaches born from nuanced scientific understanding.

Continued exploration in this field holds the key to unlocking the myriad complexities surrounding memory and cognition, thus equipping researchers and healthcare practitioners with essential tools to mitigate cognitive decline associated with aging. This research not only highlights the fascinating interconnections found within our biology but emphasizes the necessity for recognition of individual differences in cognitive strategies and health interventions.

With the field moving forward, the hope remains that a better understanding of these intricate connections will profoundly affect cognitive health strategies, ultimately enriching the human experience as we embark on the journey of life.

Subject of Research: Circadian rhythms, memory, and gene expression across age and sex

Article Title: Age and sex influence diurnal memory oscillations, circadian rhythmicity, and Per1 expression.

Article References:

Bellfy, L., Pifer, G.C., von Abo, M.J. et al. Age and sex influence diurnal memory oscillations, circadian rhythmicity, and Per1 expression.
Biol Sex Differ 16, 74 (2025). https://doi.org/10.1186/s13293-025-00756-x

Image Credits: AI Generated

DOI: 10.1186/s13293-025-00756-x

Keywords: circadian rhythm, memory, cognitive function, aging, gender differences, gene expression, Per1, diurnal oscillations, interventions, cognitive health.

The attentional boost effect (ABE) is a striking cognitive occurrence where detecting one target enhances memory for other unrelated information presented simultaneously. Essentially, when the brain zeroes in on a specific stimulus or task, nearby information tends to be better encoded, revealing an unexpected benefit in multitasking scenarios. This phenomenon has danigingly complex mechanics that researchers like Tang and Wu have sought to decode, particularly in relation to how age-related cognitive changes influence attention and memory processing.

Age is a fundamental variable in cognition, shaping how effectively the brain processes and retains information. Tang and Wu’s research makes a significant leap by systematically exploring how the attentional boost evolves from young adulthood through older age. By assessing behavioral responses and brain activity, they reveal nuanced shifts in attentional control and memory enhancement tied to aging. This helps bridge a crucial gap in cognitive neuroscience, especially given the global rise in aging populations and the imperative to maintain cognitive health.

Another pivotal aspect addressed in their study is the duration of delay tasks—intervals between stimulus presentation and the requirement to recall or act upon it. Delay tasks introduce a temporal dimension to memory retention and attentional dynamics. The researchers employed varying durations to examine how extended delays impact the attentional boost effect in individuals of different ages, ultimately uncovering temporal thresholds and resilience within attentional networks.

Using functional Near-Infrared Spectroscopy, the study shines light on the underpinnings of this phenomenon in a way rarely achievable with traditional imaging methods. fNIRS measures cortical hemodynamic responses by tracking changes in oxygenated and deoxygenated hemoglobin, thereby mapping the brain’s activity with fine temporal resolution. Tang and Wu harnessed this technology to pinpoint cortical regions implicated in attentional modulation, particularly within prefrontal and parietal cortices, regions extensively linked to executive function and attention.

Their findings highlight robust age-related disparities in the neural substrates of attention. Younger adults displayed pronounced activity in attention-associated cortical areas during tasks exhibiting the attentional boost effect, while older adults showed attenuated responses, suggesting diminished neurovascular coupling and perhaps neuronal efficiency. However, intriguingly, certain compensatory mechanisms appeared to activate under longer delay tasks, indicating adaptability within the aging brain’s attentional systems.

Moreover, the behavioral data aligned closely with the neuroimaging results. Reaction times and accuracy metrics depicted a compelling narrative—attentional boosts were consistently stronger in younger populations and when delay durations were shorter. With increasing delay intervals, the advantage diminished, and this decline was more marked among older participants. This suggests that sustained attentional engagement over time might be a critical challenge for aging brains, with implications for real-world tasks demanding prolonged focus.

Delving deeper, the authors speculate that neural plasticity mechanisms could partially account for the preservation of attentional boost benefits under specific conditions. Factors such as cognitive reserve, individual differences in vascular health, and lifestyle-based neuroprotection might help sustain attentional networks despite age-related degeneration, a hypothesis warranting further empirical inquiry. These insights shape a more dynamic and individualized understanding of cognitive aging.

Tang and Wu’s research also underscores the practical applications of their findings, particularly in designing cognitive interventions and enhancing educational or occupational tasks involving attentional demands. Understanding how delay task duration modulates attentional boosts opens avenues to structure activities that align with neurocognitive capacities at various ages, potentially mitigating age-related attentional deficits. This holds promise for tailored cognitive training programs and adaptive user-interface designs.

In addition, the integration of fNIRS as a portable, cost-effective neuroimaging tool heralds new possibilities for longitudinal and ecological validity studies. Unlike the bulky and restrictive MRI machines, fNIRS can be employed in real-world or more naturalistic settings, enabling continuous monitoring of attentional states in diverse populations. This methodological advancement could facilitate preventive strategies against cognitive decline by enabling routine attentional assessments across the lifespan.

The study by Tang and Wu also encourages a reevaluation of the neural basis of multitasking capabilities, especially when considering aging. Their evidence suggests the attentional boost effect might not just be a simple byproduct of attention but an adaptive cognitive mechanism modulating memory and perception. This perspective challenges traditional cognitive models and advances integrative theories combining attentional and memory processes under varying temporal constraints.

Furthermore, the research acknowledges some limitations and proposes future directions. While fNIRS offers excellent cortical surface resolution, deeper structures involved in attention, such as subcortical regions, remain less accessible. The authors advocate for multimodal imaging studies coupling fNIRS with EEG or fMRI to obtain a more holistic view of attentional dynamics. Also, expanding the sample size and diversity could deepen understanding across different demographic and clinical groups.

Tang and Wu’s work carries a profound message about the resilience and plasticity of the human brain. While age naturally modulates attentional systems, the brain retains remarkable capacity for adaptation, provided cognitive loads and temporal demands are balanced appropriately. These findings resonate beyond laboratories, influencing educational strategies, workforce planning, and healthcare policies aimed at optimizing cognitive function throughout life.

Ultimately, the convergence of behavioral data and neuroimaging technique like fNIRS crafts a compelling, actionable portrait of attentional function in aging. By revealing how task duration and age intertwine to shape the attentional boost effect, Tang and Wu establish a foundational stepping stone in cognitive neuroscience. Their work invites both scientists and the public to reconsider how attention and memory operate in our daily lives as we age, holding hope for enhancing quality of life through scientifically informed interventions.

This pioneering study exemplifies the potential of innovative technologies combined with rigorous behavioral paradigms to unravel the complexities of human attention. As we stand on the frontier of cognitive aging research, Tang and Wu’s contributions illuminate pathways toward maintaining mental agility in an increasingly demanding world. Harnessing such knowledge will be pivotal for fostering lifelong cognitive wellness and optimizing functional independence as we age.

As the significance of attentional processes continues to emerge in diverse domains—from education and technology to mental health and aging—this research provides spectacularly timely insight. It sparks questions about how attentional boosts might be leveraged in artificial intelligence interfaces, neurorehabilitation, and beyond, opening interdisciplinary dialogues aimed at enriching human cognitive experiences across generations.

With this landmark publication, Tang and Wu solidify the attentional boost effect as a vital lens through which to explore and enhance cognitive aging. The fusion of behavioral sophistication and advanced neuroimaging sets a new standard for cognitive neuroscience research in the 21st century, promising to propel future discoveries that improve brain health and cognitive function worldwide.

Subject of Research: The influence of age and the duration of delay tasks on the attentional boost effect, investigated through behavioral analyses and functional Near-Infrared Spectroscopy (fNIRS).

Article Title: The effects of age and delay task duration on attentional boost effect: evidence from behavior and fNIRS.

Article References:
Tang, X., Wu, Z. The effects of age and delay task duration on attentional boost effect: evidence from behavior and fNIRS. BMC Psychol 13, 1108 (2025). https://doi.org/10.1186/s40359-025-03425-1

Image Credits: AI Generated

The Clock Drawing Test has long been recognized as a simple yet effective tool to assess cognitive domains including memory, executive function, spatial abilities, and motor coordination. The digital adaptation (dCDT) offers enhanced precision and automation, delivering scores that quantify specific cognitive skills rather than a generalized outcome. By applying these measures within the framework of the Framingham Heart Study, the current research investigates whether molecular signatures of aging, particularly epigenetic modifications, can predict subtle cognitive changes before clinical symptoms manifest.

Epigenetic age acceleration is computed by examining DNAm patterns—chemical tags that regulate gene expression without altering the underlying DNA sequence. With age, DNAm profiles shift, reflecting accumulated molecular damage, exposure to environmental factors, and lifestyle influences. The acceleration metric captures the discrepancy between biological and chronological age, thus serving as a proxy for an individual’s “true” physiological aging rate. This study specifically assessed multiple established epigenetic clocks, including Horvath, PhenoAge, DunedinPACE, and GrimAge, each representing distinct facets of molecular aging.

A remarkable sample of 1,789 individuals drawn from the Framingham cohort provided the data pool, enabling the scientists to correlate biological age acceleration with subsequent dCDT performance recorded approximately seven years later. Statistically controlling for confounding variables such as baseline chronological age, sex, educational background, and blood cell composition, the researchers observed a compelling inverse association between DNAm age acceleration and dCDT scores. Notably, this relationship was most pronounced in participants aged 65 and older, underscoring potential age-dependent vulnerabilities in brain aging.

Among the epigenetic clocks analyzed, the DunedinPACE measure stood out as the most robust predictor of diminished cognitive performance in both younger and older adults. This finding suggests that this speedometer of aging not only marks age-related biological deterioration but also aligns closely with declines in neurological functions. Conversely, other clocks like Horvath and PhenoAge demonstrated significant cognitive associations primarily within the older population, implying their sensitivity to accumulated epigenetic changes manifesting in late life cognitive deficits.

The research further explored the influence of aging-related plasma proteins encapsulated within the GrimAge clock, specifically focusing on two markers: Plasminogen Activator Inhibitor-1 (PAI1) and Adrenomedullin (ADM). Elevated levels of these proteins, correlated with systemic aging and inflammation, were linked to poorer cognitive outcomes, particularly among senior participants. These protein biomarkers reinforce the concept that cognitive decline is not an isolated cerebral phenomenon but a reflection of systemic biological aging affecting multiple organ systems.

With the epigenetic clocks and protein markers collectively illustrating a molecular portrait of cognitive aging, the study presents a compelling case for the integrative monitoring of brain health. Digital cognitive testing tools like the dCDT, when paired with molecular assays of DNAm and plasma proteins, could usher in a new era of personalized aging diagnostics. Clinicians might one day utilize these combined biomarkers to detect early cognitive impairment, enabling timely intervention strategies long before overt dementia surfaces.

The mechanistic underpinnings remain a focus of ongoing research, but these epigenetic patterns likely reflect cumulative oxidative stress, chronic inflammation, and diminished cellular repair mechanisms—all processes intricately linked to neurodegenerative disease pathogenesis. Moreover, the heterogeneous associations across different epigenetic clocks reinforce the multifaceted nature of aging biology and the necessity for a composite biomarker approach rather than reliance on a single molecular indicator.

Figurative heatmaps presented in the original publication illuminate the nuanced relationships between standardized DNAm age acceleration increments and specific cognitive domains measured by the dCDT, such as spatial reasoning and motor skill execution. The P-values embedded within reveal the statistical weight of these associations, reaffirming their robustness despite adjustments for confounders. This graphical representation accentuates the precise cognitive functions most susceptible to biological aging effects, further refining potential targets for neuroprotective therapies.

The implications of this study extend beyond the realm of cognitive neuroscience and gerontology into public health and aging-related policy. Aging populations worldwide face burgeoning burdens of dementia and cognitive impairment, demanding innovative screening modalities capable of rapid, scalable deployment. The dCDT’s automated digital format combined with non-invasive blood-based epigenetic profiling presents a viable path forward, marrying technological accessibility with molecular sophistication.

Moreover, these findings challenge the long-standing primacy of chronological age in assessing brain health. By revealing how a person’s biological aging rate may diverge significantly from their chronological years, the study advocates for a paradigm shift toward more nuanced and individualized aging assessments. This molecular approach holds promise not only for early diagnosis but also for monitoring therapeutic responses and lifestyle interventions aimed at decelerating biological aging trajectories.

Ethical and practical considerations accompany the integration of these biomarkers into clinical and research settings. Issues concerning data privacy, equitable access, and interpretation of epigenetic data in diverse populations necessitate careful deliberation. Nonetheless, the clear associations established between DNAm age acceleration and cognitive decline underscore the urgency of advancing this field toward translational applications.

In summary, the Boston University-led team’s pioneering work within the longstanding framework of the Framingham Heart Study provides critical empirical evidence linking DNA methylation-based biological age acceleration with subsequent cognitive decline measured via the digital Clock Drawing Test. This convergence of epigenetic science and digital cognitive assessment heralds transformative possibilities in aging research and clinical practice, illuminating pathways to detect, track, and perhaps ultimately mitigate the ravages of cognitive aging.

Subject of Research: Not explicitly specified beyond research on molecular and cognitive aging.

Article Title: Association of DNA methylation age acceleration with digital clock drawing test performance: the Framingham Heart Study

News Publication Date: 21-Jul-2025

Web References:

• https://www.aging-us.com/issue/v17i7
• http://dx.doi.org/10.18632/aging.206285

Image Credits: © 2025 Li et al., licensed under Creative Commons Attribution License (CC BY 4.0)

Keywords: aging, epigenetic aging, DNA methylation, cognitive function, digital Clock Drawing Test